Group 1 - UTime's Hong Kong subsidiary, UTime Technology, has signed a procurement agreement worth nearly $10 million with Tumu Vertex for smart health devices [1] - The agreement includes an initial purchase order for 50,000 smart health devices, consisting of 25,000 units each of the UT-168 BT Blood Pressure Watch, UR08 ECG Smart Ring, UT-368 4G Blood Pressure Watch, and UR01 Smart Ring [1] - The first batch of products is scheduled for delivery in the first quarter of 2026, with joint quality control procedures established by both parties [1] Group 2 - UTime's CEO highlighted that this cooperation marks a significant strategic breakthrough in the North American market [1] - The order from Tumu Vertex reflects market recognition of UTime's technological capabilities and opens opportunities in the North American medical-grade wearable market [1] - UTime aims to leverage this opportunity to accelerate the development and implementation of next-generation health monitoring technologies [1]
UTime Hong Kong subsidiary secures near $10M order from Tumu Vertex